on AI/ML Innovations Inc. (CVE:AIML)
AI/ML Innovations Inc. Secures U.S. Patent for AI ECG Analysis
AI/ML Innovations Inc., through its subsidiary NeuralCloud Solutions Inc., announced the grant of a U.S. patent for AI-driven electrocardiogram (ECG) analysis techniques. The patent, No. 12,622,625 B2, covers machine learning methods for ECG denoising, rhythm classification, and signal labelling, boosting AI/ML's intellectual property portfolio.
The patent leverages advanced machine learning models to process ECG signals from wearables or other sources, producing denoised signals and rhythm classifications. This strengthens AI/ML's presence in digital health, supporting cardiac monitoring across clinical and decentralized settings.
Moreover, AI/ML Innovations disclosed a debt settlement deal, planning to issue shares to service providers. This transaction includes "related party" share purchases.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AI/ML Innovations Inc. news